Therefore, anti-TNF-α agents may have the capacity to suppress Th1 response in Th1 driven diseases, such as psoriasis, and, otherwise, Th2 response in Th2 driven diseases, such as BP, depending on the levels of INF-γ [77]. Here, TNF is linked to psoriasis.